Trademark Overview
On Monday, January 26, 2004, a trademark application was filed for TARGETED MEDICINES BY DESIGN with the United States Patent and Trademark Office. The USPTO has given the TARGETED MEDICINES BY DESIGN trademark a serial number of 78357607. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 25, 2006. This trademark is owned by MDS Inc.. The TARGETED MEDICINES BY DESIGN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives
Pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, namely conducting clinical trials of pharmaceuticals
